Immune-mediated inflammatory disease patients in the era of COVID-19 — who, how and when to vaccinate against COVID-19
Rheumatology Forum · 2022
DOI: 10.5603/fr.2021.0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology Forum, 2022. Verfasst von Olga Gumkowska-Sroka und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Patients with autoimmune diseases are a particularly vulnerable group, prone to developing infectious complications. At the same time, due to the immunosuppressive treatment of these patients, the use of vaccination may raise some concernsas to its effectiveness and, above all, its safety. This article presents the current recommendations of scientific societies indicating the efficacy, safety and, in particular, the necessity of immunization in all patients with inflammatory rheumatic diseases. Special emphasis in this study is placed on the efficacy and safety of vaccination against COVID-19.
Zitieren
APA
Gumkowska-Sroka, O., Nowak, K., & Kotyla, P. (2022). Immune-mediated inflammatory disease patients in the era of COVID-19 — who, how and when to vaccinate against COVID-19. Rheumatology Forum. https://doi.org/10.5603/fr.2021.0022
Vancouver
Gumkowska-Sroka O, Nowak K, Kotyla P. Immune-mediated inflammatory disease patients in the era of COVID-19 — who, how and when to vaccinate against COVID-19. Rheumatology Forum. 2022. doi:10.5603/fr.2021.0022
BibTeX
@article{GumkowskaSroka2022,
author = {Gumkowska-Sroka, Olga and Nowak, Karolina and Kotyla, Przemysław},
title = {Immune-mediated inflammatory disease patients in the era of COVID-19 — who, how and when to vaccinate against COVID-19},
journal = {Rheumatology Forum},
year = {2022},
doi = {10.5603/fr.2021.0022}
}
EUVIMED